Yesterday's star of the day UroGen Pharma appreciates 15.04% while outperforming its peers
Nektar Therapeutics was the biggest decliner yesterday after giving up 7.36%
European markets are down as CAC slumps to 7,520 (down 0.71%).

Before today's session: markets completed a mixed session yesterday while Nasdaq slipped 0.29% and closed at 12,037. Dow Jones gained 0.2% and closed at 33,875.

US markets are currently closed but will resume today in around 3 hours time. European markets have struggled to gain ground and are now trading lower midway through the session. Asia-Pacific markets ended a mixed session today whilst KOSPI Composite Index is down by 1.37%, reaching 2,489

PacWest Bancorp & Halliburton Co have released their earnings reports with Logitech International S.A. and Ceragon Networks Ltd. are set to publish their respective reports as scheduled.

Data to be released today might clear up some of the market fog as United States Core Durable Goods Orders expected to decline to -0.2% while its preceding data was -0.1%, data will be available tomorrow at 12:30 UTC. United States Crude Oil Inventories is projected to outperform its last figure with -1.67 million. It previously stood at -4.58 million; data will be released tomorrow at 14:30 UTC. As things stand, upcoming United States Pending Home Sales data is projected to fall short of market expectations with newly published data of 0.5%, following on from the preceding figure of 0.8%. New data is set to be published Thursday.

While markets were generally sideways yesterday, these assets pulled ahead as UroGen Pharma up 15.04% trading at $11.55. Foresight Autonomous is doing well and gains 14.84%.

With price action largely muted in yesterday's session, several assets struggled to find momentum as Nektar Therapeutics lost 7.36% yesterday before closing at 80.6 cents.

UroGen Pharma | Up 15.04% to $11.55 yesterday

UroGen Pharma Ltd. has posted further gains as part of a 3 day trend that has already seen the stock gain 38 cents. On-trend UroGen Pharma closed the session yesterday with more of the same: UroGen Pharma rallied $1.51 (15.04%) deep into the session, closing at $11.55. Daily trading volume (302,096 shares) was above the current multiday average of 154,265.

Foresight Autonomous | Up 14.84% to $2.09 yesterday

The autonomous driving system developer has fallen back around 12.92% from the significant high of $2.09 set a day ago.
Daily trading volume (1.34 million shares) increased, making up 500% of the 21-day average (269,473).

The autonomous driving system developer has fallen back around 12.92% over the past a day, from a notable high of $2.09. Foresight Autonomous's market cap is currently $156.69 million with an average daily trading volume of 269,473 shares. Foresight Autonomous expected revenue of $250,000 with an EPS of -5 cents.